Driven by a single purpose.

At PhaseWell Research, we are united by a shared commitment to advance the future of medicine. We do this by providing access to world-class clinical research to as many people as possible within the communities we serve.

Formed in 2024

PhaseWell Research is built on the foundation of trusted and well-established research sites with strong track records of success in the life sciences industry.

Among its network are renowned centers such as Renstar Medical Research (RMR) and Gabrail Cancer Center Research (GCCR) which are both recognized for their decades of expertise and consistent high-quality results.

Providing phase
I – IV clinical trial services

Offering comprehensive services across a range of therapeutic areas.

Oncology

Conducting medical research in oncology is imperative because it drives the discovery of new and more effective ways to prevent, diagnose, and treat cancer—a disease that continues to be one of the leading causes of death worldwide.

Equally crucial is the need for high-quality clinical trials and high-performing clinical sites with dedicated, skilled staff to carry out this research with premier standards of care and integrity. Through rigorous research supported by excellent trial infrastructure, reliable data, and experienced clinicians, we hope to better understand the complex biology of cancer, help develop innovative therapies, and improve patient outcomes.  

Learn More

Central Nervous System (CNS)

Central Nervous System (CNS) diseases encompass a wide range of conditions that affect the brain and spinal cord, including disorders such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, and brain tumors.

These illnesses often have devastating impacts on patients’ quality of life and can be extremely challenging to treat.  High-quality testing by dedicated clinical teams across a variety of site locations are essential to the process of bringing medical therapies to approval.  We are proud to be helping our partners develop effective treatments for individuals and families affected by these complex and often debilitating conditions.

Learn More

Cardiovascular/Metabolic

Cardiovascular and metabolic diseases include common yet serious conditions such as heart disease, stroke, hypertension, diabetes, and high cholesterol, which can lead to life-threatening complications if left untreated. These diseases are among the leading causes of death and disability worldwide, making it vital to find better ways to prevent, manage, and treat them.

Clinical studies at high-quality clinical sites play an essential role in this process to develop new therapies, improve existing treatments, and ensure patients have access to cutting-edge care.

Learn More

Dermatology

Conditions associated with dermatology range from common concerns like acne, eczema, and psoriasis to more complex or serious issues such as skin cancers, rare genetic skin disorders, and chronic inflammatory diseases. These conditions can significantly affect a person’s physical comfort, appearance, and emotional well-being.

Well-equipped clinical sites are essential to advancing dermatology care by testing new treatments, improving existing therapies, and ultimately providing patients access to the safest and most effective options available. Through high-quality research and dedicated clinical teams, patients can find better solutions to manage their skin conditions and improve their overall quality of life.

Learn More

Keeping track of success

Proud of our track record, we want to share the numbers.

25+

Years of Operational Excellence

1400+

Trials Completed

150+

Drug Approvals Enabled by Our Clinical Trials

Access to Over 13 Million Potential Participants

Across Our Network (MSA) Population

Trusted by 300+ Top Sponsors & CROs

Including 80% of Top 20 Sponsors and 90% of Top 10 CROs

25+

Years of Operational Excellence

Trusted by 300+ Top Sponsors & CROs

Including 80% of Top 20 Sponsors and 90% of Top 10 CROs

1400+

Trials Completed

Access to Over 13 Million potential Participants

Across Our Network (MSA) population

00+

Drugs Approved

Committed to advancing clinical trials

Only through innovation and improving access will we make a difference.
By streamlining site operations and forging deep healthcare partnerships, PhaseWell Research aims to bring life-changing treatments to patients faster and more efficiently.  

clinical research study
Broader Trial Access
Faster Study Start-Up
Accelerated Patient Recruitment
Improved Retention/Engaged Participants
High-Integrity Data
Uncompromising Patient Safety

Meet Our Experts

Meet the team of professionals who have joined us on this important mission.

Our Leadership

Our Independent Board Members

Learn about our Clinical Experts

Shore capital partners logos
We are proud to be partnered with Shore Capital Partners, a leading private equity firm recognized by Inc. Magazine as one of the Top 50 Founder-Friendly Firms.